Form 10-Q Karyopharm Therapeutics For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Karyopharm Therapeutics (KPTI) Files $200M Mixed Securities Shelf
November 8, 2016 8:56 AM ESTKaryopharm Therapeutics (Nasdaq: KPTI) filed a registration with the U.S. SEC to sell up to $200 million of mixed securities.
... MoreKaryopharm Therapeutics (KPTI) Tops Q3 EPS by 12c
November 7, 2016 4:28 PM ESTKaryopharm Therapeutics (NASDAQ: KPTI) reported Q3 EPS of ($0.69), $0.12 better than the analyst estimate of ($0.81).
For earnings history and earnings-related data on Karyopharm Therapeutics (KPTI) click here.
... More